{"id":10395,"date":"2026-08-11T12:47:14","date_gmt":"2026-08-11T03:47:14","guid":{"rendered":"https:\/\/kojihifu.com\/english\/?p=10395"},"modified":"2026-08-11T12:47:15","modified_gmt":"2026-08-11T03:47:15","slug":"nad-iv-tokyo-english-clinic-comparison","status":"publish","type":"post","link":"https:\/\/kojihifu.com\/english\/nad-iv-tokyo-english-clinic-comparison\/","title":{"rendered":"Where to Get NAD+ IV in Tokyo (2026 English-Speaking Clinic Guide)"},"content":{"rendered":"

By Dr. Jun Karibe, MD<\/strong> \u2014 BIOTOPE Clinic Shirokanedai, Tokyo \u00a0\u00b7\u00a0 Reviewed August 2026<\/p>\n

NAD+ IV therapy<\/strong> has become one of the most-searched longevity treatments in Tokyo. In the space of about three years it has moved from a niche biohacker curiosity into the printed menus of aesthetic and anti-aging clinics across Ginza, Roppongi and Omotesando. Prices for a single session in this city currently span from roughly \u00a530,000 for a low-dose “starter” drip to over \u00a5300,000 for a full loading protocol. The marketing language on the clinic websites is uniformly enthusiastic. The clinical picture is more measured.<\/p>\n

This guide is written for English-speaking residents and visitors in Tokyo who are trying to decide whether NAD+ IV is worth the investment, which clinic to book at, and what a physician actually thinks the therapy can and cannot do.<\/p>\n

I have kept the tone honest. NAD+ IV is a legitimate therapy<\/strong> with a defensible biochemical rationale and a growing but still early evidence base. It is also heavily oversold. Both statements are true at the same time, and a patient who understands the gap between them will make better decisions with their money and their body.<\/p>\n

I am the founder of BIOTOPE Clinic<\/strong> Shirokanedai. We offer NAD+ IV inside a broader physician-led nutritional programme rather than as a standalone drip. I explain where I think that fits, and I also flag where another clinic on this list is the better booking for a specific patient profile. Read to the end before you book \u2014 the differences between clinics on this menu matter more than the price tag suggests.<\/p>\n

What NAD+ is, and why patients are asking for it<\/h2>\n
\"NAD+<\/figure>\n

Nicotinamide adenine dinucleotide (NAD+)<\/strong> is a coenzyme present in every living cell. It is a required cofactor for hundreds of enzymatic reactions, most notably in the mitochondrial electron transport chain (which converts food into usable energy in the form of ATP), in DNA-repair enzymes called PARPs, and in the sirtuin family of enzymes that regulate cellular stress responses and metabolic housekeeping.<\/p>\n

Two facts about NAD+ have driven the current wave of interest:<\/p>\n

    \n
  1. Intracellular NAD+ concentrations decline with age.<\/strong> Multiple human tissue studies published since 2018 have documented a roughly 50 percent decline in NAD+ between young adulthood and the sixth decade of life.[1]<\/sup><\/li>\n
  2. Restoring NAD+ in animal models produces measurable improvements<\/strong> in mitochondrial function, muscle endurance, insulin sensitivity and several markers of biological ageing.[2]<\/sup><\/li>\n<\/ol>\n

    The obvious inference \u2014 that raising NAD+ in humans will slow ageing and restore energy \u2014 is where marketing has moved considerably faster than the clinical evidence. Human trials are still small, mostly focused on precursor molecules (nicotinamide riboside and nicotinamide mononucleotide) rather than intravenous NAD+ itself, and the outcomes have been mixed. Meaningful gains in some markers of muscle metabolism and cardiovascular function have been reported, but claims of reversed ageing, dramatic cognitive improvement or restored youthful energy are, to date, not backed by controlled human data at the level the marketing implies.[3]<\/sup><\/p>\n

    Patients typically ask for NAD+ IV in three situations:<\/p>\n